Literature DB >> 629607

Serum copper and related variables in rheumatoid arthritis.

P R Scudder, D Al-Timimi, W McMurray, A G White, B C Zoob, T L Dormandy.   

Abstract

Serum copper, caeruloplasmin, iron, iron-binding capacity, and antioxidant activity were measured in 120 normal subjects and in 189 patients with rheumatoid arthritis. Both serum copper and serum caeruloplasmin were significantly raised in rheumatoid disease in both sexes. A significant inverse relation was found between serum iron and serum copper, and a strong direct correlation between serum antioxidant activity and caeruloplasmin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629607      PMCID: PMC1000192          DOI: 10.1136/ard.37.1.67

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Serum copper and caeruloplasmin in ankylosing spondylitis, systemic sclerosis, and morphea.

Authors:  M I Jayson; P Davis; J T Whicher; G Walters
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

2.  Damage to microsomal membrane by lipid peroxidation.

Authors:  W R Bidlack; A L Tappel
Journal:  Lipids       Date:  1973-04       Impact factor: 1.880

3.  Assay using brain homogenate for measuring the antioxidant activity of biological fluids.

Authors:  J Stocks; J M Gutteridge; R J Sharp; T L Dormandy
Journal:  Clin Sci Mol Med       Date:  1974-09

4.  Nonceruloplasmin copper in rheumatoid arthritis.

Authors:  I Sternlieb; J I Sandson; A G Morell; E Korotkin; I H Scheinberg
Journal:  Arthritis Rheum       Date:  1969-08

5.  Determination of gold in body fluids by atomic absorption spectrophotometry.

Authors:  N D Balázs; D J Pole; J R Masarei
Journal:  Clin Chim Acta       Date:  1972-08       Impact factor: 3.786

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  The inhibition of lipid autoxidation by human serum and its relation to serum proteins and alpha-tocopherol.

Authors:  J Stocks; J M Gutteridge; R J Sharp; T L Dormandy
Journal:  Clin Sci Mol Med       Date:  1974-09

8.  The inhibition of lipid autoxidation by human caeruloplasmin.

Authors:  D J Al-Timimi; T L Dormandy
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

9.  Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis.

Authors:  D P Bajpayee
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

10.  METHOD FOR THE AUTOMATIC DETERMINATION OF SERUM IRON.

Authors:  D S YOUNG; J M HICKS
Journal:  J Clin Pathol       Date:  1965-01       Impact factor: 3.411

View more
  34 in total

1.  Early and late changes in sulphydryl group and copper protein concentrations and activities during drug treatment with aurothiomalate and auranofin.

Authors:  K J Rae; C N Mackay; C J McNeil; D H Brown; W E Smith; D Lewis; H A Capell
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

2.  Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of caeruloplasmin, transferrin and lactoferrin.

Authors:  J M Gutteridge
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

3.  Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells.

Authors:  C Broadley; R L Hoover
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

Review 4.  Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies.

Authors:  R Milanino; M Marrella; R Gasperini; M Pasqualicchio; G Velo
Journal:  Agents Actions       Date:  1993-07

5.  Carrageenan oedema in copper-deficient rats.

Authors:  R Milanino; S Mazzoli; E Passarella; G Tarter; G P Velo
Journal:  Agents Actions       Date:  1978-12

6.  Synovial fluid copper and related variables in rheumatoid and degenerative arthritis.

Authors:  P R Scudder; W McMurray; A G White; T L Dormandy
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

7.  Concerning the role of endogenous copper in the acute inflammatory process.

Authors:  R Milanino; A Conforti; M E Fracasso; L Franco; R Leone; E Passarella; G Tarter; G P Velo
Journal:  Agents Actions       Date:  1979-12

8.  Copper metabolism during acute inflammation: studies on liver and serum copper concentrations in normal and inflamed rats.

Authors:  A Conforti; L Franco; R Milanino; A Totorizzo; G P Velo
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

9.  The oxidation of serum sulph-hydryl groups by hydrogen peroxide secreted by stimulated phagocytic cells in rheumatoid arthritis.

Authors:  N D Hall; C L Maslen; D R Blake
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

10.  Serum copper: a marker of disease activity in rheumatoid arthritis.

Authors:  A A Youssef; B Wood; D N Baron
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.